ETF overview
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
Fund facts
- Expense ratio
- 0.99%
- Fund assets
- 55.86M USD (all share classes)
- Issuer
- Tema
- Inception date
- Nov 20, 2023
- Number of holdings
- 45
Breakdown
Holdings (45)
| Name | Ticker | Weight |
|---|---|---|
| ELI LILLY & CO | LLY | 11.94% |
| THERMO FISHER SCIENTIFIC INC | TMO | 5.79% |
| MERCK & CO INC | MRK | 4.61% |
| ROCHE HOLDING AG | RHHBY | 4.31% |
| UNITEDHEALTH GROUP INC | UNH | 3.67% |
| REVOLUTION MEDICINES INC | RVMD | 3.47% |
| KODIAK SCIENCES INC | KOD | 3.39% |
| BRIDGEBIO PHARMA INC | BBIO | 3.31% |
| NOVO NORDISK A/S | NOVO-B.CO | 3.25% |
| JOHNSON & JOHNSON | JNJ | 3.23% |
| and 32 more | ||
Similar ETFs
- iShares Global Healthcare ETFIXJ · Overlap 59% · Expense ratio 0.38%
- State Street Health Care Select Sector SPDR ETFXLV · Overlap 54% · Expense ratio 0.08%
- iShares U.S. Healthcare ETFIYH · Overlap 54% · Expense ratio 0.37%
- Vanguard Health Care ETFVHT · Overlap 53% · Expense ratio 0.09%
- Fidelity MSCI Health Care Index ETFFHLC · Overlap 53% · Expense ratio 0.08%
- Xtrackers MSCI World Health Care UCITS ETF 1CXDWH.DE · Overlap 60% · Expense ratio 0.25%
- State Street SPDR MSCI World Health Care UCITS ETFWHEA.L · Overlap 60% · Expense ratio 0.30%
- BetaShares - Global Healthcare Currency Hedged ETFDRUG.AX · Overlap 60% · Expense ratio 0.57%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
- Expense ratio
- 0.99%
- Fund assets
- 55.86M USD (all share classes)
- Issuer
- Tema
- Inception date
- Nov 20, 2023
- Number of holdings
- 45
| Name | Ticker | Weight |
|---|---|---|
| ELI LILLY & CO | LLY | 11.94% |
| THERMO FISHER SCIENTIFIC INC | TMO | 5.79% |
| MERCK & CO INC | MRK | 4.61% |
| ROCHE HOLDING AG | RHHBY | 4.31% |
| UNITEDHEALTH GROUP INC | UNH | 3.67% |
| REVOLUTION MEDICINES INC | RVMD | 3.47% |
| KODIAK SCIENCES INC | KOD | 3.39% |
| BRIDGEBIO PHARMA INC | BBIO | 3.31% |
| NOVO NORDISK A/S | NOVO-B.CO | 3.25% |
| JOHNSON & JOHNSON | JNJ | 3.23% |
| and 32 more | ||
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
- iShares Global Healthcare ETFIXJ · Overlap 59% · Expense ratio 0.38%
- State Street Health Care Select Sector SPDR ETFXLV · Overlap 54% · Expense ratio 0.08%
- iShares U.S. Healthcare ETFIYH · Overlap 54% · Expense ratio 0.37%
- Vanguard Health Care ETFVHT · Overlap 53% · Expense ratio 0.09%
- Fidelity MSCI Health Care Index ETFFHLC · Overlap 53% · Expense ratio 0.08%
- Xtrackers MSCI World Health Care UCITS ETF 1CXDWH.DE · Overlap 60% · Expense ratio 0.25%
- State Street SPDR MSCI World Health Care UCITS ETFWHEA.L · Overlap 60% · Expense ratio 0.30%
- BetaShares - Global Healthcare Currency Hedged ETFDRUG.AX · Overlap 60% · Expense ratio 0.57%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free